Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
42%

OVERLAP
BY WEIGHT
11

# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
41%
ALSO IN XLV
XLV
60
HOLDINGS
18%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus XLV)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in XLV
Overlap
ELI LILLY & CO 16.7% 14.4% 14.4%
ABBVIE INC 8.4% 7.1% 7.1%
JOHNSON & JOHNSON 5.7% 10.3% 5.7%
MERCK & CO. INC. 3.9% 5.3% 3.9%
AMGEN INC 4.3% 3.6% 3.6%
MEDX Overweight Relative to XLV
NOVARTIS AG-ADR 7.7%
ASTRAZENECA PLC 5.7%
IONIS PHARMACEUTICALS, INC. 4.8%
ALNYLAM PHARMACEUTICALS INC 3.9%
ALKERMES PLC 3.3%
GLAXOSMITHKLINE PLC-SPON ADR 3.2%
CRISPR THERAPEUTICS AG 3.0%
BRISTOL-MYERS SQUIBB CO 2.8%
BIOGEN IDEC INC 2.3%
ELI LILLY & CO 2.3%
MEDX Underweight Relative to XLV
JOHNSON & JOHNSON -4.7%
UNITEDHEALTH GROUP INC -4.6%
ABBOTT LABORATORIES -3.5%
THERMO FISHER SCIENTIFIC INC -3.4%
GILEAD SCIENCES INC -3.2%
INTUITIVE SURGICAL INC -3.1%
STRYKER CORP -2.3%
DANAHER CORP -2.3%
VERTEX PHARMACEUTICALS INC -2.2%
MEDTRONIC PLC -2.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY